{
    "2014-06-02": [
        "Discussant of intra-lesional melanoma therapy posters said future studies must combine with PD-1s to be relevant.",
        "Amgen is showing resistance near $117.40.",
        "Amgen presents new data on Talimogene Laherparepvec as single agent and combination therapy in metastatic melanoma at ASCO.",
        "Seeking the next stock like $LXK, $AMGN, $AAPL."
    ]
}